MeSH term
Frequency | Condition_Probility | Child, Preschool | 3 | 0.0 |
Collagen/*genetics | 17 | 3.0 |
Female | 12 | 0.0 |
Haplotypes | 2 | 0.0 |
Humans | 28 | 0.0 |
Male | 10 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Pedigree | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Animals | 7 | 0.0 |
Comparative Study | 5 | 0.0 |
Exons/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Collagen/genetics | 3 | 3.0 |
Fibrosis | 2 | 1.0 |
Mice | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Transfection | 2 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Adult | 5 | 0.0 |
Aged | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
Adolescent | 3 | 0.0 |
Alleles | 2 | 0.0 |
Base Sequence | 11 | 0.0 |
Child | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Abnormalities, Multiple/*genetics/pathology | 2 | 2.0 |
Connective Tissue Diseases/*genetics/pathology | 2 | 40.0 |
Ear/abnormalities | 2 | 20.0 |
Eye Diseases, Hereditary/genetics/pathology | 2 | 66.0 |
Face/abnormalities | 2 | 3.0 |
Joints/abnormalities | 2 | 66.0 |
*Linkage (Genetics) | 3 | 0.0 |
Mutation | 3 | 0.0 |
Syndrome | 4 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Ehlers-Danlos Syndrome/*genetics | 3 | 10.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Procollagen/*genetics | 3 | 2.0 |
*Chromosomes, Human, Pair 2 | 5 | 1.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Cell Line | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Joint Instability/*genetics | 2 | 66.0 |
Lod Score | 3 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Phenotype | 2 | 0.0 |
*Genetic Markers | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
DNA/genetics | 2 | 0.0 |
DNA Primers | 2 | 0.0 |